Author

Linda M. Clayton

Observed names: Clayton, Linda M, Linda Clayton, Linda M Clayton

Observed institutions: University of North Carolina at Chapel Hill, Mayo Clinic, GlaxoSmithKline (United Kingdom), UC San Diego Health System, Jewish General Hospital, University of Alabama at Birmingham, University of California San Diego, University of Illinois Chicago, GlaxoSmithKline (United States), Duke Medical Center, University of California San Diego Medical Center, Columbia University

OpenAlex ID: A5110188504

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 · Robyn J. Barst, Lewis J. Rubin, et al. · New England Journal of Medicine · 2,698

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

2002 · Ronald J Raymond, Alan L Hinderliter, et al. · Journal of the American College of Cardiology · 827

Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension

1997 · Alan L. Hinderliter, Park W. Willis, et al. · Circulation · 318

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension

1999 · Alan L Hinderliter, Park W Willis, et al. · The American Journal of Cardiology · 164

Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension

2003 · Alan L. Hinderliter, Park W. Willis, et al. · The American Journal of Cardiology · 85

Continuous Infusion of Epoprostenol Improves the Net Balance Between Pulmonary Endothelin-1 Clearance and Release in Primary Pulmonary Hypertension

1999 · David Langleben, Robyn J. Barst, et al. · Circulation · 78

Effect of the Glycine Antagonist Gavestinel on Cerebral Infarcts in Acute Stroke Patients, a Randomized Placebo-Controlled Trial: The GAIN MRI Substudy

2005 · Steven Warach, David Kaufman, et al. · Cerebrovascular Diseases · 57

Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose‐ranging study

2017 · Steven Thornton, Guillermo Valenzuela, et al. · British Journal of Clinical Pharmacology · 14

Determination of Chenodiol Bioequivalence Using an Immobilized Multi-Enzyme Bioluminescence Technique

1986 · Steven S. Rossi, Linda M. Clayton, et al. · Journal of Pharmaceutical Sciences · 11

350: A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of retosiban, a selective oxytocin receptor antagonist, for the management of preterm labor

2012 · Jerry Snidow, Hugh Miller, et al. · American Journal of Obstetrics and Gynecology · 8

Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension

1997 · Alan L. Hinderliter, Park W. Willis, et al. · Pneumologie · 2

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

2021 · Willis, Park W, Clayton, Linda M, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

中文目錄表

2006 · Raoul Eckhardt, Constança Pául, et al. · Cerebrovascular Diseases

日本語目次

2006 · Raoul Eckhardt, Constança Pául, et al. · Cerebrovascular Diseases

Echocardiographic predictors of exercise capacity in primary pulmonary hypertension

1996 · Alan L. Hinderliter, Park W. Willis, et al. · Journal of the American College of Cardiology

Works count: 15

Citation count: 4,262

H-index: 9

I10-index: 9